Physicochemical Properties, Toxicity, and Specific Activity of a Follitropin Alpha Biosimilar


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Comparative analysis of the primary structure of recombinant human follicle-stimulating hormone (r-hFSH) in samples of follitropin alpha biosimilar (FAB) preparation and the reference drug Gonal-F showed they were identical while spectral analysis of their secondary and tertiary structures indicated they were bioequivalent. Analytical results for N-glycans and sialic acids revealed that the main glycan structures were similar and the distributions of the main forms of sialic acids in the compared samples differed insignificantly. Results of in vitro and in vivo biological activity testing confirmed that FAB and Gonal-F were equivalent with respect to WHO standards. Comparative testing of the acute and subacute toxicity did not reveal significant differences between the two drugs and also confirmed they were identical. Thus, the investigation proved that FAB and the reference drug were equivalent with respect to the main physicochemical, pharmacodynamic, and toxicological characteristics.

作者简介

I. Vorob’ev

Federal Research Centre for Fundamentals of Biotechnology, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 33 – 2 Leninskii Prosp., Moscow, 119071

O. Proskurina

All-Russia Scientific Center for Safety Testing of Biologically Active Substances, Ministry of Public Health of the Russian Federation

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 23 Kirov St., Staraya Kupavna, Noginskii District, Moscow Oblast, 142450

Yu. Khodak

Federal Research Centre for Fundamentals of Biotechnology, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 33 – 2 Leninskii Prosp., Moscow, 119071

A. Gosudarev

N. F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Russian Ministry of Health

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 18 Gamaleya St., Moscow, 123098

A. Semikhin

N. F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Russian Ministry of Health

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 18 Gamaleya St., Moscow, 123098

D. Byrikhina

N. F. Gamaleya Federal Research Centre for Epidemiology and Microbiology, Russian Ministry of Health

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 18 Gamaleya St., Moscow, 123098

M. Krasil’shchikova

Shemyakin—Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 16/10 Miklukho-Maklaya St., Moscow, 117997

B. Mel’nik

Institute of Protein Research, Russian Academy of Sciences

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 4 Institutskaya St., Pushchino, Moscow Oblast, 142290

M. Serebryakova

A. N. Belozersky Institute of Physicochemical Biology, Moscow State University

Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 1/40 Leninskie Gory, Moscow, 119992

M. Polzikov

IVPharma Co.

编辑信件的主要联系方式.
Email: mikhail.polzikov@gmail.com
俄罗斯联邦, 20/2 Nauchnyi Proezd, Moscow, 117246


版权所有 © Springer Science+Business Media New York, 2017
##common.cookie##